| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taurine (2-aminoethanesulfonic acid) is a sulfur-containing “amino acid–like” molecule (not incorporated into proteins). It’s abundant in many tissues and is best thought of as a homeostatic modulator rather than a direct cytotoxin.Core biology themes: -Osmoregulation / membrane stabilization -Mitochondrial support + anti-oxidant tone (indirect) -Calcium handling modulation -Anti-inflammatory signaling (context-dependent) -Bile acid conjugation (tauroursodeoxycholic-type physiology, but taurine itself is a conjugating substrate) Cancer relevance (preclinical/adjunct framing): -Often discussed as protective (normal-tissue protection) and stress-modulating, not a primary anti-cancer agent. -May influence redox balance, ER stress, and inflammation, which can indirectly affect tumor biology or therapy tolerance (model-dependent). -ROS axis: tends to reduce oxidative injury (indirect) -NRF2: sometimes reported as part of antioxidant adaptation, but not a “core direct target”Amino acid that benefits the heart, brain and immune system. Taurine, an organic compound containing sulfur in its chemical structure, possesses anti-inflammatory, anti-oxidant, and various physiological functions within the cardiovascular, kidney, endocrine, and immune systems. Also an LDH inhibitor -Neuroprotection: helps protect neurons against excitotoxicity (e.g., glutamate damage) and ROS stress. -Anti-oxidative action: scavenges ROS, reducing oxidative stress seen in AD brains. -Anti-inflammatory -Calcium homeostasis Helps maintain intracellular calcium balance, disrupted in AD. -Amyloid-beta toxicity May reduce Aβ-induced neurotoxicity and cell death in vitro. -Tau pathology: possible reduction of tau hyperphosphorylation. -Memory and cognition may improve learning and memory.
Time-Scale Flag (TSF): P / R / G
Alzheimer’s Disease (AD)-Oriented Time-Scale Flagged Pathway Table
Time-Scale Flag (TSF): P / R / G
|
| Source: |
| Type: enzyme |
| HK2 (Hexokinase 2) is an enzyme that plays a crucial role in glycolysis, the process by which cells convert glucose into energy. HK2 is a key regulatory enzyme in the glycolytic pathway, and it is primarily expressed in various tissues, including muscle, brain, and cancer cells. HK2 has been shown to be overexpressed in many types of tumors, including breast, lung, and colon cancer. This overexpression may contribute to the development and progression of cancer by promoting glycolysis and energy production in cancer cells. HK2 is a key regulatory enzyme in the glycolytic pathway. HK2 plays a role in the regulation of glucose metabolism in diabetes. HK2 is involved in the regulation of cell proliferation, apoptosis, and autophagy. HK2 Inhibitors: -2DG -Curcumin -Resveratrol -EGCG -Berberine -Methyl Jasmonate (MJ) -Honokiol |
| - | in-vitro, | Nor, | HSC-T6 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:158 Target#:773 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid